SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-22-275013
Filing Date
2022-11-01
Accepted
2022-11-01 16:51:36
Documents
9

Document Format Files

Seq Description Document Type Size
1 S-3 d413257ds3.htm S-3 412109
2 EX-1.2 d413257dex12.htm EX-1.2 219793
3 EX-4.1 d413257dex41.htm EX-4.1 266572
4 EX-5.1 d413257dex51.htm EX-5.1 34215
5 EX-5.2 d413257dex52.htm EX-5.2 9532
6 EX-23.2 d413257dex232.htm EX-23.2 2121
7 EXHIBIT 107 d413257dexfilingfees.htm EX-FILING FEES 50926
8 GRAPHIC g413257dsp81.jpg GRAPHIC 2603
9 GRAPHIC g413257g02o03.jpg GRAPHIC 44831
  Complete submission text file 0001193125-22-275013.txt   1057005
Mailing Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140
Business Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140 (617) 221-9059
Pyxis Oncology, Inc. (Filer) CIK: 0001782223 (see all company filings)

IRS No.: 831160910 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-268100 | Film No.: 221351170
SIC: 2834 Pharmaceutical Preparations